Arvinas Ownership | Who Owns Arvinas?
Arvinas Ownership Summary
Arvinas is owned by 92.25% institutional investors, 7.79% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.73% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.
ARVN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arvinas | 92.25% | 7.79% | -0.04% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 8.25M | 12.73% | $63.82M |
| Vanguard group | 7.23M | 9.92% | $85.74M |
| Blackrock | 6.26M | 8.70% | $166.61M |
| Logos global management lp | 5.58M | 7.66% | $47.50M |
| Vanguard portfolio management | 4.18M | 6.45% | $32.31M |
| D. e. shaw | 3.50M | 5.46% | $29.04M |
| Pfizer | 3.46M | 5.34% | $26.24M |
| Armistice capital | 2.80M | 4.37% | $23.23M |
| Vanguard capital management | 2.68M | 4.13% | $20.69M |
| Two sigma investments, lp | 2.57M | 4.02% | $21.39M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 1.59M | 31.38% | $13.51M |
| Pfizer | 3.46M | 15.98% | $26.24M |
| Aquilo capital management | 328.77K | 9.50% | $6.30M |
| Nextech invest | 1.41M | 4.38% | $27.00M |
| Logos global management lp | 5.58M | 4.26% | $47.50M |
| Rangeley capital | 175.59K | 1.33% | $1.46M |
| Opaleye management | 987.82K | 1.19% | $8.42M |
| Arbiter partners capital management | 325.42K | 1.07% | $2.52M |
| Boxer capital | 608.61K | 0.85% | $16.20M |
| Nextech invest | 1.12M | 0.81% | $17.12M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Logos global management lp | 5.58M | 4.26% | 2.27M |
| Affinity asset advisors | 2.05M | 0.65% | 2.05M |
| Norges bank | 1.24M | 0.00% | 1.24M |
| Armistice capital | 2.80M | 0.28% | 818.00K |
| Blackrock | 6.26M | 0.00% | 764.55K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -6.73M |
| Rtw investments, lp | - | - | -3.33M |
| Bellevue group | - | - | -2.39M |
| Paradigm biocapital advisors lp | - | - | -2.34M |
| Alyeska investment group | - | - | -1.80M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Affinity asset advisors | 2.05M | 0.65% | 2.05M | $15.86M |
| Norges bank | 1.24M | 0.00% | 1.24M | $23.84M |
| Mackenzie financial | 686.07K | 0.01% | 686.07K | $5.31M |
| Occudo quantitative strategies lp | 124.65K | 0.06% | 124.65K | $1.04M |
| Martingale asset management l p | 82.63K | 0.02% | 82.63K | $639.15K |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| Truvestments capital | -1.00 |
| Capital performance advisors llp | -6.00 |
| Turning point benefit group | -7.00 |
| Silver grove financial group | -7.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 200 | -2.91% | 59,776,777 | 6.53% | 92 | 1.23% | 107 | -7.76% | 51 | - |
| Jun 30, 2026 | 203 | -3.79% | 56,021,993 | 3.53% | 87 | 1.22% | 115 | 18.56% | 50 | -29.58% |
| Mar 31, 2026 | 77 | -63.16% | 11,747,414 | -78.99% | 18 | 0.31% | 39 | -60.20% | 19 | -73.61% |
| Dec 31, 2025 | 124 | -44.14% | 33,193,014 | -50.49% | 45 | 0.54% | 57 | -47.22% | 41 | -40.58% |
| Sep 30, 2025 | 210 | -4.98% | 63,374,662 | 4.16% | 87 | 1.25% | 101 | -20.47% | 66 | 29.41% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 2.38M | 3.46% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.92M | 2.98% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.92M | 2.98% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.92M | 2.94% | - |
| Vanguard US Total Market Shares ETF | 1.93M | 2.81% | 2.43K |
| Vanguard Strategic Equity Inv | 1.71M | 2.61% | - |
| iShares Russell 2000 ETF | 1.52M | 2.32% | - |
| Vanguard Explorer Inv | 896.37K | 1.37% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 755.96K | 1.16% | 28.83K |
| Vanguard Small Cap Index | 841.18K | 1.15% | -5.64K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 09, 2026 | Loomis David K | VP, Chief Accounting Officer | Sell | $1.48K |
| Jun 24, 2026 | Saik Andrew | Chief Financial Officer | Sell | $46.47K |
| Jun 17, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | $19.56K |
| May 21, 2026 | Teel Randy | President and CEO | Sell | $19.96K |
| May 11, 2026 | Saik Andrew | Chief Financial Officer | Sell | $110.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 1 |
| 2026 Q2 | - | 8 |
| 2026 Q1 | 1 | 14 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | 1 | - |
ARVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools